
REPLIGEN CORP
RGENNASDAQ๐ #821 by market capEarnings Oct 26 ยท PreUS Equity
$164.77โฒ $1.61 (+0.98%)
๐
Pre-market$164.86โฒ 0.05%Regular close ยท extended-hours price shown1hโ
24hโฒ 1.0%
7dโฒ 3.8%
14dโฒ 16.5%
30dโฒ 13.8%
1yโฒ 35.7%
๐ฆMarket Cap
$9.30B
Small Cap
๐Revenue Growth (YoY)
+16.5%
Healthy
๐Gross Margin
53.8%
Healthy
๐ตFCF Margin
14.0%
Healthy
โ๏ธP/S Ratio
11.7x
Elevated
Otter Score
43
Weak
๐
Analyst Ratings
Price
$164.77
Total
24
Raised
4
Lowered
0
Avg PT
$152.00
H / L
$160 / $142
| Institution | Action | Rating | Date |
|---|---|---|---|
Wells Fargo | Reiterated | Overweight | 2026-07-30 |
JP Morgan | Reiterated | Overweight | 2026-07-29 |
Benchmark | Upgraded | Hold โ Buy | 2026-07-07 |
Evercore ISI Group | Reiterated | Outperform | 2026-07-06 |
HSBC | Reiterated | Buy | 2026-06-03 |
Barclays | Reiterated | Overweight | 2026-05-06 |
Canaccord Genuity | Reiterated | Hold | 2026-04-20 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-23 |
UBS | Reiterated | Buy | 2026-02-25 |
Jefferies | Reiterated | Hold | 2025-09-12 |
RBC Capital | Reiterated | Outperform | 2025-07-30 |
Stephens & Co. | Reiterated | Overweight | 2024-07-30 |
Deutsche Bank | Upgraded | Hold โ Buy | 2024-06-26 |
Stifel | Reiterated | Buy | 2024-02-22 |
Keybanc | Reiterated | Overweight | 2024-02-15 |
Craig-Hallum | Reiterated | Buy | 2023-08-03 |
SVB Leerink | Reiterated | Outperform | 2023-01-06 |
Exane BNP Paribas | Reiterated | Outperform | 2021-10-14 |
KeyBanc | Reiterated | Overweight | 2020-11-10 |
Stifel Nicolaus | Reiterated | Buy | 2020-02-21 |
First Analysis | Upgraded | Outperform โ Strong Buy | 2019-11-01 |
H.C. Wainwright | Upgraded | Neutral โ Buy | 2019-07-22 |
Citigroup | Reiterated | Buy | 2018-07-20 |
CL King | Reiterated | Buy | 2017-11-13 |
One row per institution, most recent rating